Roivant Sciences

Roivant Sciences is a publicly traded biopharmaceutical company that develops and commercializes medicines by building and operating focused subsidiary companies known internally as "Vants." It applies technology across drug discovery, development, and commercialization, and its subsidiaries have produced multiple FDA-approved treatments, including VTAMA for psoriasis. Roivant Health is the company's internal healthcare-technology business unit, distinct from its drug-development subsidiaries like Immunovant, Priovant, and Pulmovant.